Haemonetics Corporation (HAE)
NYSE: HAE · Real-Time Price · USD
54.38
+0.30 (0.55%)
At close: Sep 5, 2025, 4:00 PM
54.38
0.00 (0.00%)
After-hours: Sep 5, 2025, 7:00 PM EDT
Haemonetics Stock Forecast
Stock Price Forecast
The 11 analysts that cover Haemonetics stock have a consensus rating of "Buy" and an average price target of $86.73, which forecasts a 59.49% increase in the stock price over the next year. The lowest target is $62 and the highest is $116.
Price Target: $86.73 (+59.49%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Haemonetics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 5 | 4 |
| Buy | 3 | 3 | 3 | 4 | 4 | 5 |
| Hold | 2 | 2 | 2 | 2 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 10 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Strong Buy → Buy Downgrades $105 → $78 | Strong Buy → Buy | Downgrades | $105 → $78 | +43.44% | Aug 11, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $95 → $86 | Buy | Maintains | $95 → $86 | +58.15% | Aug 8, 2025 |
| Mizuho | Mizuho | Buy Maintains $90 → $70 | Buy | Maintains | $90 → $70 | +28.72% | Aug 8, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $85 → $62 | Buy → Hold | Downgrades | $85 → $62 | +14.01% | Aug 8, 2025 |
| Needham | Needham | Strong Buy Maintains $84 → $68 | Strong Buy | Maintains | $84 → $68 | +25.05% | Aug 7, 2025 |
Financial Forecast
Revenue This Year
1.31B
from 1.36B
Decreased by -3.88%
Revenue Next Year
1.39B
from 1.31B
Increased by 6.50%
EPS This Year
4.87
from 3.31
Increased by 47.21%
EPS Next Year
5.54
from 4.87
Increased by 13.76%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.4B | 1.5B | |
| Avg | 1.3B | 1.4B | |
| Low | 1.2B | 1.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.0% | 13.8% | |
| Avg | -3.9% | 6.5% | |
| Low | -8.3% | 0.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.13 | 6.10 | |
| Avg | 4.87 | 5.54 | |
| Low | 4.64 | 5.09 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 55.1% | 25.2% | |
| Avg | 47.2% | 13.8% | |
| Low | 40.0% | 4.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.